市場調查報告書
商品編碼
1451412
按產品類型(手動、自動)、樣本類型(血液、胚胎、卵子、精液)、最終用戶(血庫、醫院、組織庫、製藥和生物技術公司等)和地區分類的醫療解凍系統市場報告 2024- 2032Medical Thawing System Market Report by Product Type (Manual, Automated), Sample Type (Blood, Embryo, Ovum, Semen), End User (Blood Banks, Hospitals, Tissue Banks, Pharmaceutical and Biotech Companies, and Others), and Region 2024-2032 |
2023年,全球醫用解凍系統市場規模達到2.055億美元。展望未來, IMARC Group預計到2032年市場規模將達到3.728億美元,2024-2032年複合年成長率(CAGR)為6.63%。慢性病盛行率的不斷上升、對再生和個人化藥物的需求不斷成長以及持續的技術進步是推動市場發展的一些關鍵因素。
醫用解凍系統用於醫療機構安全快速地解凍血液製品、疫苗和組織樣本等冷凍生物標本。它採用受控過程,在水浴中加熱和攪拌冷凍樣本,使其均勻解凍,而不會對樣本造成任何損壞。除此之外,它們還有助於最大限度地降低污染風險,確保檢測結果準確可靠,並降低處理冷凍標本的醫護人員受傷的風險。醫用解凍系統符合處理生物材料的嚴格監管標準,對於確保解凍標本的品質和功效至關重要。因此,它作為可靠、高效和標準化的設備廣泛應用於各種醫療機構,以確保患者護理和研究中使用的生物樣本的品質和功效。
患有慢性疾病以及病毒和細菌感染的人數不斷增加是推動市場成長的主要因素之一。與此一致的是,器官移植傾向的不斷增強和器官捐贈者的增加,加上輸血需求的激增,正在為市場創造良好的前景。除此之外,對再生醫學的需求不斷擴大,推動了對幹細胞、組織和其他生物樣本安全有效解凍的需求,這反過來又促進了市場的成長。此外,創新技術的進步,例如自動化和機器人技術的整合,以提高解凍系統的效率和準確性,正在為市場帶來豐厚的成長機會。此外,COVID-19病毒的爆發推動了組織標本的收集,以研究感染的生物學影響並確定新的治療干預措施和預防策略,這對市場成長產生了積極影響。其他因素,例如老年人口不斷增加、醫療保健支出增加、參與捐血活動的人數不斷增加、對個性化藥物的需求不斷增加,以及為開發治療罕見疾病的有效療法而對研發(R&D) 項目進行的大量投資,正在加強市場成長。
The global medical thawing system market size reached US$ 205.5 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 372.8 Million by 2032, exhibiting a growth rate (CAGR) of 6.63% during 2024-2032. The increasing prevalence of chronic diseases, the rising demand for regenerative and personalized medicines, and ongoing technological advancements represent some of the key factors driving the market.
A medical thawing system is used in healthcare facilities to thaw frozen biological specimens such as blood products, vaccines, and tissue samples safely and quickly. It employs a controlled process of heating and agitating the frozen specimen in a water bath, allowing it to thaw evenly without causing any damage to the sample. In addition to this, they help minimize the risk of contamination, ensure accurate and reliable test results, and reduce the risk of injury to healthcare workers handling frozen specimens. The medical thawing system meets strict regulatory standards for handling biological materials and is essential in ensuring the quality and efficacy of the thawed specimen. As a result, it is widely employed across various healthcare facilities as a reliable, efficient, and standardized device for ensuring the quality and efficacy of biological samples used in patient care and research.
The rising number of individuals suffering from chronic diseases and viral and bacterial infections is one of the primary factors driving the market growth. In line with this, the growing inclination toward organ transplantation and an increase in organ donors combined with the surging demand for blood transfusions is creating a favorable outlook for the market. In addition to this, the expanding demand for regenerative medicine is fuelling the need for safe and efficient thawing of stem cells, tissues, and other biological samples, which, in turn, is contributing to the market growth. Moreover, innovative technological advancements, such as the integration of automation and robotics technology to enhance the efficiency and accuracy of thawing systems, are presenting remunerative growth opportunities for the market. Furthermore, the outbreak of the COVID-19 virus has impelled the collection of tissue specimens for researching the biological impact of the infection and identifying new therapeutic interventions and prevention strategies, which is positively impacting the market growth. Other factors, such as the rising geriatric population, increasing healthcare expenditure, growing number of people participating in blood donation campaigns, the escalating demand for personalized medicines, and extensive investments in research and development (R&D) projects to develop effective therapies for treating rare diseases, are strengthening the market growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global medical thawing system market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product type, sample type and end user.
Manual
Automated
The report has provided a detailed breakup and analysis of the medical thawing system market based on the product type. This includes manual and automated. According to the report, the manual represented the largest segment.
Blood
Plasma
Stem Cells
Whole Blood
Platelets
Embryo
Ovum
Semen
A detailed breakup and analysis of the medical thawing system market based on the sample type has also been provided in the report. This includes blood (plasma, stem cells, whole blood and platelets), embryo, ovum and semen. According to the report, blood accounted for the largest market share.
Blood Banks
Hospitals
Tissue Banks
Pharmaceutical and Biotech Companies
Others
The report has provided a detailed breakup and analysis of the medical thawing system market based on the end-user. This includes blood banks, hospitals, tissue banks, pharmaceutical and biotech companies, and others. According to the report, blood banks represented the largest segment.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for medical thawing system. Some of the factors driving the North America medical thawing system market included the growing prevalence of life-threatening chronic diseases, the increasing adoption of regenerative and personalized medicines, and the rising geriatric population.
The report has also provided a comprehensive analysis of the competitive landscape in the global medical thawing system market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Barkey GmbH & Co. KG, Biolife Solutions Inc., Boekel Scientific, Cardinal Health Inc., General Electric Company, Helmer Scientific Inc., Hospicare Systems, labcold Limited, MMS Medical and Laboratory Supplies, Sarstedt AG & Co. KG, Sartorius AG, Terumo Penpol Private Limited (Terumo Corporation) and Thermo Fisher Scientific Inc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.